Autonomix Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Public

  • Employees
  • 11

Employees

  • Stock Symbol
  • AMIX

Stock Symbol

  • Share Price
  • $1.37
  • (As of Friday Closing)

Autonomix General Information

Description

Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 21 Waterway Avenue
  • Suite 300
  • The Woodlands, TX 77380
  • United States
+1 (713)
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Technology Systems
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 21 Waterway Avenue
  • Suite 300
  • The Woodlands, TX 77380
  • United States
+1 (713)

Autonomix Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Autonomix Stock Performance

As of 13-Nov-2026, Autonomix’s stock price is $1.37. Its current market cap is $2.8M with 2.05M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.37 $1.35 $1.30 - $32.55 $2.8M 2.05M 1.98M -$39.67

Autonomix Financials Summary

As of 30-Jun-2026, Autonomix has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV (3,625) (5,483) (6,381) 57,048
Revenue 0 0 0 0
EBITDA (16,372) (17,022) (11,405) (15,393)
Net Income (16,106) (16,715) (11,410) (15,426)
Total Assets 3,980 7,600 9,806 9,407
Total Debt 0 0 0 1,002
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Autonomix Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Autonomix‘s full profile, request access.

Request a free trial

Autonomix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Autonomix‘s full profile, request access.

Request a free trial

Autonomix Patents

Autonomix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025222085-A1 Medical device guide sheaths with return electrodes for bipolar therapeutic electroporation Pending 19-Apr-2024
WO-2025222080-A1 Medical devices configured for temperature-controlled therapeutic electroporation Pending 19-Apr-2024
WO-2025244764-A1 Medical devices configured for therapeutic electroporation with adjustable sections of an elongate member Pending 19-Apr-2024
WO-2025244764-A8 Medical devices configured for therapeutic electroporation with adjustable sections of an elongate member Pending 19-Apr-2024
EP-4568603-A1 Medical devices configured for therapeutic electroporation of biologic tissues Pending 03-Aug-2022 A61B18/1492
To view Autonomix’s complete patent history, request access »

Autonomix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Autonomix ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

37.03 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,585

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Autonomix’s complete esg history, request access »

Autonomix FAQs

  • When was Autonomix founded?

    Autonomix was founded in 2014.

  • Where is Autonomix headquartered?

    Autonomix is headquartered in The Woodlands, TX.

  • What is the size of Autonomix?

    Autonomix has 11 total employees.

  • What industry is Autonomix in?

    Autonomix’s primary industry is Other Devices and Supplies.

  • Is Autonomix a private or public company?

    Autonomix is a Public company.

  • What is Autonomix’s stock symbol?

    The ticker symbol for Autonomix is AMIX.

  • What is the current stock price of Autonomix?

    As of 13-Nov-2026 the stock price of Autonomix is $1.37.

  • What is the current market cap of Autonomix?

    The current market capitalization of Autonomix is $2.8M.

  • What is Autonomix’s annual earnings per share (EPS)?

    Autonomix’s EPS for 12 months was -$39.67.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process